| 英文名称 |
中文名称 |
CAS号 |
操作 |
| IC-87114 |
2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 |
371242-69-2 |
详细
|
| GSK2578215A |
5-(2-氟-4-吡啶基)-2-(苯基甲氧基)-N-3-吡啶基苯甲酰胺 |
1285515-21-0 |
详细
|
| HA15 |
HA-15 |
1609402-14-3 |
详细
|
| Alvelestat (AZD9668) |
ALVELESTAT |
848141-11-7 |
详细
|
| Amuvatinib;MP470 |
N-(1,3-苯并二氧戊环-5-基甲基)-4-苯并呋喃并[3,2-D]嘧啶-4-基-1-哌嗪硫代甲酰胺 |
850879-09-3 |
详细
|
| SP2509 |
SP2509 |
1423715-09-6 |
详细
|
| STF-62247 |
N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 |
315702-99-9 |
详细
|
| SR9243 |
N-[2-(3-溴苯基)乙基]-2,4,6-三甲基-N-[[3'-(甲基磺酰基)[1,1'-联苯]-4-基]甲基]苯磺酰胺 |
1613028-81-1 |
详细
|
| Radotinib;IY5511 |
拉多替尼 |
926037-48-1 |
详细
|
| MI 2 (MALT1 inhibitor) |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 |
1047953-91-2 |
详细
|
| WAY-362450;XL335 |
3-(3,4-二氟苯甲酰基)-1,2,3,6-四氢-1,1-二甲基氮杂卓[4,5-B]吲哚-5-甲酸 1-甲基乙基酯 |
629664-81-9 |
详细
|
| BMS-863233;XL413 (hydrochloride) |
XL413 (BMS-863233) |
1169562-71-3 |
详细
|
| CZ415 |
CZ415 |
1429639-50-8 |
详细
|
| GKT137831 |
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 |
1218942-37-0 |
详细
|
| GSK1059615 |
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 |
958852-01-2 |
详细
|
| KY02111 |
KY 02111 |
1118807-13-8 |
详细
|
| GSK583 |
6-(叔丁基磺酰基)-N-(5-氟-1H-吲唑-3-基)喹啉-4-胺 |
1346547-00-9 |
详细
|
| IOX2 |
IOX 2 |
931398-72-0 |
详细
|
| KN-92 hydrochloride |
KN-92 盐酸盐 |
1431698-47-3 |
详细
|
| Remodelin HBr |
REMODELIN |
1622921-15-6 |
详细
|
| Merestinib |
梅沙替尼 |
1206799-15-6 |
详细
|
| Necrostatin-1 |
NECROSTATIN-1 |
4311-88-0 |
详细
|
| PFI 4;PFI-4 |
N-(1,3-二甲基-2-氧代-6-(吡咯烷-1-基)-2,3-二氢-1H-苯并[D]咪唑-5-基)-2-甲氧基苯甲酰胺 |
900305-37-5 |
详细
|
| PRX-08066 |
PRX-08066 |
866206-54-4 |
详细
|
| NVP-LDE225 |
索尼吉布 |
956697-53-3 |
详细
|
| KN-93 hydrochloride |
化合物 T21557 |
1956426-56-4 |
详细
|
| MK-8745 |
MK8745 |
885325-71-3 |
详细
|
| GSK503 |
化合物GSK503 |
1346572-63-1 |
详细
|
| Enasidenib |
恩西地平 |
1446502-11-9 |
详细
|
| RO 61-8048 |
RO 61-8048 |
199666-03-0 |
详细
|
| ly2784544 |
LY 2784544 |
1229236-86-5 |
详细
|
| U-104;NSC-213841 |
U-104 |
178606-66-1 |
详细
|
| STF-31 |
4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺 |
724741-75-7 |
详细
|
| StemRegenin 1 (SR1) |
SR-1;SR1 |
1227633-49-9 |
详细
|
| BMS-707035 |
N-[(4-氟苯基)甲基1,6-二氢-5-羟基-1-甲基-6-氧代-2-(四氢-1,1-二氧-2H-1,2-噻嗪-2-基)-4-嘧啶甲酰胺 |
729607-74-3 |
详细
|
| BI 9564 |
化合物BI9564 |
1883429-22-8 |
详细
|
| XAV-939 |
3,5,7,8-四氢-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮 |
284028-89-3 |
详细
|
| Tiplaxtinin(PAI-039) |
替普沙汀 |
393105-53-8 |
详细
|
| BTZ043 |
2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 |
1161233-85-7 |
详细
|
| GSK2801 |
GSK2801 |
1619994-68-1 |
详细
|
| CI-994(Tacedinaline) |
4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺 |
112522-64-2 |
详细
|
| GNF-7 |
GNF-7 |
839706-07-9 |
详细
|
| LY2584702 tosylate salt |
LY2584702 TOSYLATE |
1082949-68-5 |
详细
|
| BMS-582949 |
BMS 582949 |
623152-17-0 |
详细
|
| TP-0903 |
TP-0903 |
1341200-45-0 |
详细
|
| ABT-751;E7010 |
N-[2-[(4-羟基苯基)氨基]-3-吡啶基]-4-甲氧基苯磺酰胺 |
141430-65-1 |
详细
|
| Bikinin |
Bikinin |
188011-69-0 |
详细
|
| WHI-P154 |
2-溴-4-(6,7-二甲氧基喹唑啉-4-基氨基)苯酚 |
211555-04-3 |
详细
|
| ADX 47273 |
(S)-(4-氟苯基)-{3-[3-(4-氟苯基)-[1,2,4]二唑-5-基]哌啶-1-基}甲酮 |
851881-60-2 |
详细
|
| LXR623 |
2-[(2-氯-4-氟苯基)甲基]-3-(4-氟苯基)-7-(三氟甲基)-2H-吲唑 |
875787-07-8 |
详细
|
| BQU57 |
BQU57 |
1637739-82-2 |
详细
|
| 4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide |
BLZ945 |
953769-46-5 |
详细
|
| AZD1080 |
AZD1080 |
612487-72-6 |
详细
|
| Necrosulfonamide |
N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 |
1360614-48-7 |
详细
|
| Napabucasin (BBI608) |
2-乙酰基呋喃并-1,4-萘醌 |
83280-65-3 |
详细
|
| PD-1/PD-L1 inhibitor 1 |
PD-1 |
1675201-83-8 |
详细
|
| PND-1186,SR-2156 |
PND1186 |
1061353-68-1 |
详细
|
| PF-06447475 |
PF-06447475 |
1527473-33-1 |
详细
|
| PF-4708671 |
PF-4708671 |
1255517-76-0 |
详细
|
| VGX-1027 |
4,5-DIHYDRO-3-PHENYL-5-ISOXAZOLEACETICACID |
6501-72-0 |
详细
|
| TG-101209 |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
详细
|
| SB 203580 |
4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑 |
152121-47-6 |
详细
|
| DMXAA |
2,5-己酮可可碱 |
117570-53-3 |
详细
|
| AGI5198 |
AGI-5198 (IDH-C35) |
1355326-35-0 |
详细
|
| ABT-199 |
ABT-199 |
1257044-40-8 |
详细
|
| AMI-1 |
猩红酸钠盐 |
20324-87-2 |
详细
|
| Epacadostat (INCB024360) |
艾卡哚司他 |
1204669-58-8 |
详细
|
| MLN1117,INK1117 |
[6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮 |
1268454-23-4 |
详细
|
| MK-4101 |
5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑 |
935273-79-3 |
详细
|
| C-DIM12 |
C-DIM12 |
178946-89-9 |
详细
|
| CCT007093 |
(2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮 |
176957-55-4 |
详细
|
| BAY11-7082 |
(E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE |
19542-67-7 |
详细
|
| Ceralasertib |
AZD6738 |
1352226-88-0 |
详细
|
| BMS-794833 |
BMS-794833 |
1174046-72-0 |
详细
|
| NVP-BEP800 |
NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE |
847559-80-2 |
详细
|
| LY 294002 |
LY294002/PI3K抑制剂 |
154447-36-6 |
详细
|
| MX-69 |
MX69 |
1005264-47-0 |
详细
|
| GSK591 （EPZ-015866） |
GSK591 (EPZ-015866) |
1616391-87-7 |
详细
|
| Losmapimod;GW856553X |
Losmapimod (GW856553X) |
585543-15-3 |
详细
|
| T0901317 |
N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺 |
293754-55-9 |
详细
|
| PF-CBP1 HCl |
化合物PF-CBP1 |
1962928-21-7 |
详细
|
| OICR-9429 |
OICR-9429 |
1801787-56-3 |
详细
|
| SCH 58261 |
SCH58261 |
160098-96-4 |
详细
|
| SC-202671 |
SC-202671 |
312917-14-9 |
详细
|
| SB505124 |
SB-505124 |
694433-59-5 |
详细
|
| RVX-208 |
RVX-208 |
1044870-39-4 |
详细
|
| RO4929097 |
N1-[(7S)-6,7-二氢-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]-2,2-二甲基-N3-(2,2,3,3,3-五氟丙基)丙二酰胺 |
847925-91-1 |
详细
|
| RKI-1447 |
1-(3-羟基苄基)-3-(4-(吡啶-4-基)噻唑-2-基)脲 |
1342278-01-6 |
详细
|
| PTC-209 |
PTC-209 |
315704-66-6 |
详细
|
| RBC8 |
RBC8 |
361185-42-4 |
详细
|
| PKI-587;Gedatolisib |
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-吗啉基)-1,3,5-三嗪-2-基]苯基]脲 |
1197160-78-3 |
详细
|
| Varespladib (LY315920) |
伐瑞拉迪 |
172732-68-2 |
详细
|
| AZD2858 |
AZD2858 |
486424-20-8 |
详细
|
| AGI-6780 |
AGI-6780 |
1432660-47-3 |
详细
|
| Akti-1/2 |
1,3-二氢-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮 |
612847-09-3 |
详细
|
| AdipoRon |
阿迪普隆 |
924416-43-3 |
详细
|
| XL019 |
XL019 |
945755-56-6 |
详细
|
| WH-4-023 |
2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE |
837422-57-8 |
详细
|
| WY-14643 (Pirinixic Acid) |
匹立尼酸 |
50892-23-4 |
详细
|
| C646 |
C646 |
328968-36-1 |
详细
|